Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19

Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19
复制标题

OATP4C1 在瑞德西韦及其核苷类似物 GS-441524 肾脏处理中的作用:首个获批用于治疗 COVID-19 患者的药物

DOI:
10.18433/jpps31813
复制
发表时间:
2021
期刊:
Journal of Pharmacy & Pharmaceutical Sciences
影响因子:
--
通讯作者:
Yamaguchi Hiroaki
Yamaguchi Hiroaki
中科院分区:
--
文献类型:
--
作者:
Sato Toshihiro;Maekawa Masamitsu;Mano Nariyasu;Abe Takaaki;Yamaguchi Hiroaki

文献摘要

相似文献